US Stock MarketDetailed Quotes
EGRX Eagle Pharmaceuticals
- 4.280
- -0.130-2.95%
Trading May 6 13:59 ET
55.46MMarket Cap4.86P/E (TTM)
4.600High4.280Low28.36KVolume4.470Open4.410Pre Close124.32KTurnover0.27%Turnover Ratio1.57P/E (Static)12.96MShares23.52052wk High0.22P/B44.33MFloat Cap3.95052wk Low--Dividend TTM10.36MShs Float104.170Historical High--Div YieldTTM7.25%Amplitude3.950Historical Low4.382Avg Price1Lot Size
About Eagle Pharmaceuticals Company
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Company Profile
SymbolEGRX
Company NameEagle Pharmaceuticals
Listing DateFeb 12, 2014
Issue Price15.00
Founded2007
CEOMr. Michael Graves
MarketNASDAQ
Employees134
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address50 Tice Boulevard,Suite 315
CityWoodcliff Lake
ProvinceNew Jersey
CountryUnited States of America
Zip Code07677-9991
Phone1-201-326-5300
Websitehttp://www.eagleus.com
Company Executives
- Name
- Position
- Salary
- Steven B. Ratoff
- Interim Chief Financial Officer, Principal Accounting Officer and Independent Director
- 331.03K
- Michael Graves
- Interim Executive Chairman of the Board and Interim Principal Executive Officer
- 391.03K
- Richard A. Edlin
- Independent Director
- 312.28K
- Robert L. Glenning
- Independent Director
- 324.78K
- Dr. Luciana Borio, M.D.
- Independent Director
- 308.53K
- Dr. Jennifer K Simpson, PhD
- Independent Director
- 308.53K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg